Anke van den Berg
prof. dr.
I work as a clinical molecular biologist in the department of Pathology. In this function I supervise and implement advanced molecular diagnostic techniques. Within my research line, I focus on the molecular pathogenesis of B-cell Hodgkin and non-Hodgkin lymphoma. The specific fields of interest are genomic aberrations, genetic susceptibility, and the role of small and long noncoding RNAs. I have several international collaborations and am PI and co-PI in various projects.
EXPRESSION OF THE C-MET ONCOGENE CORRELATES WITH FAVORABLE PROGRESSION FREE SURVIVAL IN CLASSICAL HODGKIN LYMPHOMA
C. Xu, A. van den Berg, W. Plattel, N. Ruether, X. Huang, M. Wang, D. de Jong, H. Vos, G. van Imhoff, A. Viardot, P. Moeller, S. Poppema, A. Diepstra, L. Visser
PROSPECTIVE ANALYSIS OF PLASMA LEVELS OF THYMUS AND ACTIVATION REGULATED CHEMOKINE (TARC) IN PRIMARY AND RELAPSED CLASSICAL HODGKIN LYMPHOMA PATIENTS
W. Plattel, A. van den Berg, A. M. Van der Graaf, S. Poppema, L. Visser, A. Diepstra, G. W. Van Imhoff
EXPRESSION AND FUNCTION OF TOLL LIKE RECEPTORS TLR4, TLR7 AND TLR9 IN CLASSICAL HODGKIN LYMPHOMA
C. Xu, L. Visser, A. Diepstra, P. Moeller, S. Poppema, A. van den Berg
HLA EXPRESSION AND GENETIC ASSOCIATIONS IN EBV POSITIVE AND EBV NEGATIVE CLASSICAL HODGKIN LYMPHOMA
A. Diepstra, B. Hepkema, H. Xin, C. Xu, K. Kushekhar, R.J.M. Nolte, L. Visser, S. Poppema, A. van den Berg
THE ROLE OF MIRNAS IN HODGKIN LYMPHOMA
A. van den Berg, Ping L. Tan, J. Gibcus, J. Kluiver, Slezack-Prochzka, N. Halsema, D. de Jong, B-J Kroesen, S. Poppema